Epidemiological Evaluation of Hematological Malignancies in HIV-Positive Patients at Lady Reading Hospital, Peshawar Pakistan

Main Article Content

Dr. Muhammad Nisar,Dr. Nisar Ahmad ,Dr.Asad Ullah,Dr Saeed Ullah ,Dr. Muhammad Waqar Farooqi ,Fawad Khan

Keywords

HIV; Hematological Malignancies; Antiretroviral Therapy; Immunodeficiency; Epidemiology of Cancer; Lymphoma.

Abstract

HIV causes immunodeficiency because of retroviruses; it predisposes a patient to opportunistic infections and malignancy. HMs constitute a major clinical problem for populations infected with HIV, especially in areas where fully developed ART is not accessed.

Abstract 185 | PDF Downloads 93

References

1. Biggar, R. J., Chaturvedi, A. K., Goedert, J. J., & Engels, E. A. (2007). AIDS-related cancer and severity of immunosuppression in persons with
AIDS. Journal of the National Cancer Institute, 99(12), 962-972. https://doi.org/10.1093/jnci/djm010
2. Crum-Cianflone, N., Hullsiek, K. H., Marconi, V., Weintrob, A., Ganesan, A., Barthel, R. V., ... & Agan, B. K. (2010). Trends in the incidence of
cancers among HIV-infected persons and the impact of antiretroviral therapy: A 20-year cohort study. AIDS (London, England), 24(10), 1505.
https://doi.org/10.1097/QAD.0b013e 32833a3a3b